biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The bioasis puppet

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 21, 2023 8:14pm

49 Views

Post# 35598992

RE:RE:RE:The bioasis puppet

Yes, I do believe her, TT, because I believe she knows xB3 works, and that is why she wanted to go with LT and The Gang.

She set it up so that she got herself sold off to the people who were buying Bioasis and xB3.

TT, why would she and LT spend two years setting it up? Just for giggles?

We know.

You're just a big kidder.

jd

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024